Putative Complementary Compounds to Counteract Insulin-Resistance in PCOS Patients
Authors:
- Tabatha PetrilloTPTabatha Petrillo
- Elisa SempriniESElisa Semprini
- Veronica TomatisVTVeronica Tomatis
- Melania ArnesanoMAMelania Arnesano
- Fedora AmbrosettiFAFedora Ambrosetti
- Christian BattipagliaCBChristian Battipaglia
- Alessandra SponzilliASAlessandra Sponzilli
- Francesco RicciardielloFRFrancesco Ricciardiello
- Andrea R. GenazzaniAGAndrea R. Genazzani
- Alessandro D. GenazzaniAlessandro D. Genazzani
Open Access
- 9 August 2022
- journal article
- review article
- Published by MDPI AG in Biomedicines
- Vol. 10 (8) , 1924
Abstract
Polycystic ovary syndrome (PCOS) is the most frequent endocrine-metabolic disorder among women at reproductive age. The diagnosis is based on the presence of at least two out of three criteria of the Rotterdam criteria (2003). In the last decades, the dysmetabolic aspect of insulin resistance and compensatory hyperinsulinemia have been taken into account as the additional key features in the etiopathology of PCOS, and they have been widely studied. Since PCOS is a complex and multifactorial syndrome with different clinical manifestations, it is difficult to find the gold standard treatment. Therefore, a great variety of integrative treatments have been reported to counteract insulin resistance. PCOS patients need a tailored therapeutic strategy, according to the patient’s BMI, the presence or absence of familiar predisposition to diabetes, and the patient’s desire to achieve pregnancy or not. The present review analyzes and discloses the main clinical insight of such complementary substances.Keywords
This publication has 175 references indexed in Scilit:
- Potential role and therapeutic interests of myo-inositol in metabolic diseasesBiochimie, 2013
- Mechanisms for Insulin Resistance: Common Threads and Missing LinksCell, 2012
- The Adapter Protein APPL1 Links FSH Receptor to Inositol 1,4,5-Trisphosphate Production and Is Implicated in Intracellular Ca2+ MobilizationEndocrinology, 2011
- Diabetes and Alpha Lipoic AcidFrontiers in Pharmacology, 2011
- Lipoic Acid Synthase (LASY)Diabetes, 2009
- Insulin-stimulated release of d-chiro-inositol–containing inositolphosphoglycan mediator correlates with insulin sensitivity in women with polycystic ovary syndromeMetabolism, 2008
- Laparoscopic Surgery in Polycystic Ovary Syndrome: Reproductive and Metabolic EffectsSeminars in Reproductive Medicine, 2008
- Gymnema sylvestre: A MemoirJournal of Clinical Biochemistry and Nutrition, 2007
- α-Lipoic acid increases insulin sensitivity by activating AMPK in skeletal muscleBiochemical and Biophysical Research Communications, 2005
- Both myo-inositol to chiro-inositol epimerase activities and chiro-inositol to myo-inositol ratios are decreased in tissues of GK type 2 diabetic rats compared to Wistar controlsBiochemical and Biophysical Research Communications, 2002